EcoR1 Capital, LLC

EcoR1 Capital, LLC reported 36 holdings worth US$2.25B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

EcoR1 Capital, LLC reported 36 holdings worth US$2.25B as of Sep 30, 2026. Largest: Zymeworks Inc., AnaptysBio, Inc. and CG Oncology, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
36
Value as reported
US$2.25B

The filing in full

CompanySharesValue as reported% of portfolio
Zymeworks Inc.23MUS$608M27.0%
AnaptysBio, Inc.7.88MUS$396M17.6%
CG Oncology, Inc.1.87MUS$133M5.9%
Eton Pharmaceuticals, Inc.2.47MUS$127M5.6%
First Tracks Biotherapeutics, Inc.3.17MUS$113M5.0%
Aktis Oncology, Inc.4.82MUS$93.9M4.2%
Alto Neuroscience, Inc.2.23MUS$57M2.5%
Lakefront Biotherapeutics1.67MUS$49.4M2.2%
Erasca, Inc.2.95MUS$43.2M1.9%
ORIC Pharmaceuticals, Inc.3.03MUS$40.8M1.8%
Neurogene Inc.1.27MUS$35.4M1.6%
Attovia Therapeutics, Inc.2.02MUS$34.7M1.5%
Fulcrum Therapeutics, Inc.6.8MUS$25.2M1.1%
ADARx Pharmaceuticals, Inc.1.15MUS$22.9M1.0%
Stoke Therapeutics, Inc.835KUS$21.7M0.96%
Zenas BioPharma, Inc.790KUS$21.3M0.95%
Electra Therapeutics, Inc.1.7MUS$19.1M0.85%
Atara Biotherapeutics, Inc.1.55MUS$13.2M0.59%
Capricor Therapeutics, Inc.1.38MUS$13M0.58%
Xencor, Inc.500KUS$12.5M0.55%
Odyssey Therapeutics, Inc.556KUS$12.3M0.55%
Aura Biosciences, Inc.1.67MUS$10.5M0.46%
Nurix Therapeutics, Inc.375KUS$8.89M0.39%
Braveheart Bio, Inc.417KUS$8.42M0.37%
Eikon Therapeutics, Inc.856KUS$6.88M0.31%
Eloxx Pharmaceuticals, Inc.400KUS$6.12M0.27%
Aardvark Therapeutics, Inc.720KUS$3.79M0.17%
BridgeBio Oncology Therapeutics, Inc.890KUS$3.65M0.16%
TCGX Acquisition Corp.250KUS$3.13M0.14%
Zura Bio Limited680KUS$2.83M0.13%
Helix Acquisition Corp. III200KUS$2.12M0.09%
Contineum Therapeutics, Inc.64,303US$863K0.04%
MBX Biosciences, Inc.0US$00.00%
Phathom Pharmaceuticals, Inc.0US$00.00%
Relay Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related